#EFISG
LightNews LightNews
olivercornely.bsky.social
Great energy at the European Fungal Infection Study Group (EFISG) Business Meeting! Exceptionally active educational efforts and many exciting new studies endorsed. Big things ahead! #EFISG #ESCMID2025 #FungalInfections
April 12, 2025 at 5:08 PM
olivercornely.bsky.social
Last Friday (Oct 15), @salmantongarcia.bsky.social spoke in Porto at the 1st Course on Invasive Fungal Infections, endorsed by the @EFISG-ESCMID Fungal Infection Study Group, sharing insights on the epidemiology and clinical challenges in HIV and other immunocompromised individuals. #IFIs #EFISG
October 13, 2025 at 12:46 PM
efisg-escmid.bsky.social
28 Oct, 08:00 CET – Disseminated fusariosis (with MMIG): uni-koeln.zoom.us/meeting/regi...
Welcome! You are invited to join a meeting: EFISG in collaboration with MMIG | Disseminated Fusariosis: From a Challenging Case to Practical Clinical Management. After registering, you will receive a ...
- Web Symposium | - Disseminated Fusariosis: From a Challenging Case to Practical Clinical Management Join this Study Group Websymposium, organized by EFISG in collaboration with MMIG, focusing on th...
uni-koeln.zoom.us
September 29, 2026 at 10:04 AM
youngisham.bsky.social
If you are a member of the Young ISHAM community, the ISHAM council has exciting news for you...

@olivercornely.bsky.social @neil-gow.bsky.social @youngecmm.bsky.social @efisg-escmid.bsky.social
January 12, 2026 at 2:41 PM
efisg-escmid.bsky.social
🚀 Over 150 people tuned in live! Thank you all for joining! 🙌

See you next on March 25th, 16:30–17:30 CET

🔹 Antifungal prophylaxis in...

1) Haematological malignancies
2) Solid organ transplantation

📢 Past #EFISG webinars and register for upcoming ones!

🔗https://www.escmid.org/efisg/#c4007
March 6, 2025 at 5:34 PM
olivercornely.bsky.social
New nationwide ESCMID-EFISG study on fungal infection care in Colombia: major gaps in diagnostics, limited access to advanced tools & antifungals, with strong urban–rural disparities. www.sciencedirect.com/science/arti... @salmantongarcia.bsky.social @escmid.bsky.social @efisg-escmid.bsky.social
Diagnostic and therapeutic capacity for fungal infections in Colombia: An ESCMID-EFISG nationwide multicenter assessment of mycological healthcare
This study aims to evaluate nationwide diagnostic and treatment capacity for IFD across Colombia’s diverse healthcare system.Between March and Septemb…
www.sciencedirect.com
November 27, 2025 at 8:37 AM
efisg-escmid.bsky.social
#EFISGWebinar alert!

Invasive mould wound infection – lessons from regions under conflicts

📅 18.02.2025
🕒 15:00–16:00 CET

🔗 us06web.zoom.us/webinar/register/WN_j8aeC7qPQ22H9x7rGQxjmw#/registration

Next webinars to come... www.escmid.org/efisg/#c4007

@escmid.bsky.social @taescmid.bsky.social
February 17, 2025 at 9:57 AM
efisg-escmid.bsky.social
EFISG webinars 🍄

8 Oct: IFI at autopsy
13 Oct: Phaeohyphomycosis
28 Oct: Disseminated fusariosis
6 Nov: Water, fungi and health
17 Nov: Difficult & curious cases

Links below 👇
Welcome! You are invited to join a webinar: EFISG & ESGFOR: Invasive Fungal Infections diagnosis at autopsy: cases and discussion. After registering, you will receive a confirmation email about joinin...
Chairs Jon Salmanton-García & Domitille Callon Speakers: Pediatric case – Forensic Point of view Domitille Callon Adult case – Microbiologist Point of view Jean-Pierre Gangneux Pathology diagn...
us06web.zoom.us
September 29, 2026 at 10:04 AM
neil-gow.bsky.social
Great day in FAILSAFE co-sponsored symposium on fungal AMR in Bangkok. @mrccmm.bsky.social @efisg @escmid.bsky.social @youngecmm.bsky.social @youngisham.bsky.social @msgerc.bsky.social @gw4amr.bsky.social
November 1, 2025 at 2:11 PM
escmid.bsky.social
The Mobile Lab returns to #ESCMIDGlobal2026. Claire Rogers returns with workshops exploring parasitology as well as expanding into fungal identification and culture techniques thanks to the Fungal Infections Study Group (EFISG). Secure your spot today! https://ow.ly/uQrX50Y60et

#IDSky #clinmicro
February 2, 2026 at 2:10 PM
germhuntermd.bsky.social
Candida Endocarditis: current perspectives on diagnosis and therapy

Ben-Ami Ronen, Bassetti Matteo, Bouza Emilio, Kosman Alex, Vena Antonio on behalf of @efisg-escmid.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119... #MedMycoSky #IDSky
Candida Endocarditis: current perspectives on diagnosis and therapy
Candida infective endocarditis (CIE) is a rare but potentially devastating condition. Although it accounts for only 1-1.5% of infective endocarditis cases, CIE carries a high mortality rate (36-49%) a...
www.clinicalmicrobiologyandinfection.com
June 8, 2025 at 2:10 PM
efisg-escmid.bsky.social
Join us for our next #EFISGWebinar—free & open to all!

Missed it live? On demand: escmid.org/efisg

Invasive fungal diseases in immunocompromised children

6 March 2025 | 🕓 16:00–18:00 CET Register here: us06web.zoom.us/webinar/regi...

@escmid.bsky.social @taescmid.bsky.social
EFISG
Welcome to the homepage for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
escmid.org
March 4, 2025 at 2:09 PM
olivercornely.bsky.social
New publication in #MedicalMycology: “Profiling medical mycologists” by the #ESCMID #FungalInfection Study Group (#EFISG).
Survey of 342 experts from 72 countries highlights the diversity, collaboration, and future needs. @salmantongarcia.bsky.social

pubmed.ncbi.nlm.nih.gov/41995303/
#GlobalHealth
Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG) - PubMed
Invasive fungal infections are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing antifungal resistance, unequal access to diagnostics and ther...
pubmed.ncbi.nlm.nih.gov
May 18, 2026 at 8:41 AM
salmantongarcia.bsky.social
🚨 #Antifungal #prophylaxis in #SOT patients is evolving—but not uniformly.

A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers.

👇👇
link.springer.com/article/10.1...
Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC - Infection
Introduction Invasive fungal diseases (IFD) present serious risks to solid organ transplant recipients, particularly in the first 180 days post-transplant. Existing European and US guidelines offer li...
link.springer.com
July 4, 2025 at 3:11 PM
olivercornely.bsky.social
We invite you to participate in a survey about antifungal prophylaxis in patients with hematological malignancies. It will take 15-20 minutes. Your input helps shed light on current practices. Thank you! 🙏🦠💉
www.clinicalsurveys.net/uc/AFproph_H...
@efisg-escmid.bsky.socialsky.social #Hematology
Survey
www.clinicalsurveys.net
February 18, 2025 at 10:50 AM
olivercornely.bsky.social
Today & tomorrow in Madrid: the Invasive Fungal Infections Course 🦠 (Oct 1–2, 16:00–19:30 CET) at Hospital Gregorio Marañón. Free & online! 🔗 docs.google.com/forms/d/e/1F...
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
October 1, 2025 at 10:44 AM
efisg-escmid.bsky.social
Next #EFISG webinars...

Antifungal prophylaxis in different patient populations
📅 25 March 2025
🕓 16:30–18:00 CET
Register here: us06web.zoom.us/webinar/regi...

More to come!

@escmid.bsky.social @taescmid.bsky.social @esgem-sg.bsky.social @ishamycology.bsky.social
March 17, 2025 at 8:36 PM
olivercornely.bsky.social
📊 New ESCMID-EFISG survey on IFI diagnostic & treatment capacity in Benelux shows gaps in access & azole resistance testing. Read the full study here: onlinelibrary.wiley.com/doi/10.1111/...
#InvasiveFungalInfections #AntifungalResistance #ESCMID
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance
Introduction Invasive fungal infections (IFI) are a major clinical challenge, particularly in immunocompromised patients, and are associated with high morbidity and mortality. With the increasing pr...
onlinelibrary.wiley.com
July 14, 2025 at 1:10 PM
fhagen.bsky.social
Candida auris MIC testing by EUCAST and clinical and laboratory standards institute broth microdilution, and gradient diffusion strips; to be or not to be amphotericin B resistant? @escmid.bsky.social #EFISG #EUCAST doi.org/10.1016/j.cm...
December 18, 2024 at 11:32 AM
olivercornely.bsky.social
Join the EFISG webinar “Women in Science – Past, Present, and Future” 🧬
📅 11 Feb 2026 | 🕕 18:00 CET
🎓 Inspiring speakers & discussions on women’s careers in science.
👉 Register: us06web.zoom.us/webinar/regi...
@salmantongarcia.bsky.social
#EFISG_FREE_WEBINAR
January 23, 2026 at 9:12 AM
efisg-escmid.bsky.social
6 Nov, 15:00 CET – Water, fungi and health: us06web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: EFISG: Water, Fungi and Health: Exploring an Emerging Interface. After registering, you will receive a confirmation email about joining the webinar.
Chairs Jon Salmanton-García Kate Medlicott Speakers: Antifungal resistance should become a water quality concern and a One Health governance issue João Brandão Wastewater in Asia as an Evolutiona...
us06web.zoom.us
September 29, 2026 at 10:04 AM
salmantongarcia.bsky.social
🧪New @efisg-escmid.bsky.social study!

How 🇧🇪🇳🇱🇱🇺 diagnose and treat invasive #fungal infections

🔬 PCR, GM, MALDI-TOF MS, triazoles and more—big 🇧🇪 vs 🇳🇱 differences in diagnostics & access

📊 Must-read!

🧵

🔗 onlinelibrary.wiley.com/doi/10.1111/...

@escmid.bsky.social @olivercornely.bsky.social
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance
Introduction Invasive fungal infections (IFI) are a major clinical challenge, particularly in immunocompromised patients, and are associated with high morbidity and mortality. With the increasing pr.....
onlinelibrary.wiley.com
July 14, 2025 at 6:52 AM
olivercornely.bsky.social
High mortality in ICU patients with Pneumocystis jirovecii pneumonia (PJP): A post-hoc analysis by ESGCIP & EFISG reveals 30-day mortality of 52.7%. Non-HIV conditions emerge as key risk factors. Read more: pubmed.ncbi.nlm.nih.gov/40515506/
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG - PubMed
PJP mortality remains high in ICU patients. Conditions other than HIV infection are emerging not only as non-classical risk factors for PJP development, but also as important mortality predictors. A b...
pubmed.ncbi.nlm.nih.gov
July 23, 2025 at 11:04 AM
isacworld.bsky.social
🔴 LIVE NOW

🎙️Last but by no means least Anuradha Chowdhary, Prof. of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi & Secretary General of ISAC presents on Emergence & spread of resistance in #Candidaspecies
🔗 tinyurl.com/5y4mxvj4
#FungalInfections
@efisg-escmid.bsky.social
November 3, 2025 at 11:26 AM
isacworld.bsky.social
*Webinar Alert*
WHO Fungal Priority Pathogens List

📅 3 Nov 2025 | 🕚 11:00–12:30 CET
Explore global challenges in fungal diagnostics & resistance with experts from ISAC & ESCMID

🔗 Register: tinyurl.com/5n84ecaf
#FungalInfections #AntifungalResistance
@escmid.bsky.social @efisg-escmid.bsky.social
October 6, 2025 at 12:37 PM